Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 3,622 shares at $45.46 ($162K) on 2019-04-09, disclosed to the SEC on 2019-04-11.
Scheduled sale ($162k) by SVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.24 | 70 | $3K | 1.9% |
| 2 | $44.62 | 3,452 | $154K | 95.3% |
| 3 | $45.46 | 100 | $5K | 2.8% |
| Total | $44.64 avg | 3,622 | $162K | 100% |
| Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $196K | — | Filing → |